These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34903507)

  • 1. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
    Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.
    Muehleisen B; Jiang SB; Gladsjo JA; Gerber M; Hata T; Gallo RL
    PLoS One; 2012; 7(7):e40754. PubMed ID: 22808251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
    Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
    Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
    Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours.
    Khorshid SM; Glover MT; Churchill L; McGregor JM; Proby CM
    J Cutan Pathol; 1996 Jun; 23(3):229-33. PubMed ID: 8793657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
    Ng JC; Cumming S; Leung V; Chong AH
    Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
    Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
    Keller B; Braathen LR; Marti HP; Hunger RE
    Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
    Ramsay HM; Harden PN; Reece S; Smith AG; Jones PW; Strange RC; Fryer AA
    J Invest Dermatol; 2001 Aug; 117(2):251-5. PubMed ID: 11511301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment.
    Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Hopkins P; Chambers D; Campbell S; Isbel NM; Soyer HP; Olsen CM; Ellis JJ; Whiteman DC; Green AC; MacGregor S
    J Invest Dermatol; 2021 Dec; 141(12):2866-2875.e2. PubMed ID: 34089721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
    Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
    Abikhair Burgo M; Roudiani N; Chen J; Santana AL; Doudican N; Proby C; Felsen D; Carucci JA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.